MIM SurePlan LiverY90 is a specialized software solution designed to provide timesaving tools for nuclear medicine professionals involved in Y90 radioembolization treatments. It focuses on efficient liver and tumor segmentation, deformable registration, and precise post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT imaging. The software can be utilized as a standalone application or integrated seamlessly into the broader MIM ecosystem, offering a comprehensive, vendor-neutral platform for nuclear medicine processing and review. The system addresses critical roadblocks in Y90 therapy by enabling clinicians to confidently determine the actual dose received by patients, overcoming the uncertainties associated with traditional planning methods. It supports reading PET/CT, PET/MR, SPECT/CT, and planar Nuclear Medicine images from any major manufacturer, consolidating image review into a single system. By providing patient-specific dosimetry, MIM SurePlan LiverY90 empowers oncologists with increased confidence in Y90 as a legitimate treatment option, facilitating informed decisions on subsequent treatment paths. A study highlighted a 70% reduction in time compared to manual liver outlining, underscoring its efficiency.

Features & Benefits

• Efficient Post-Y90 Analysis
  • Provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT.
• Comprehensive Image Compatibility
  • Reads PET/CT, PET/MR, SPECT/CT, and planar Nuclear Medicine images from any major manufacturer within one system.
• Enhanced Treatment Confidence
  • Overcomes limitations in knowledge and certainty for subsequent Y90 treatments by providing patient-specific dosimetry.
• Optimized Treatment Evaluations
  • Facilitates precise treatment evaluations with volume segmentation, deformable registration, and post-dosimetry treatment.
• Patient-Specific Dosimetry
  • Calculates the actual dose delivered, overcoming the uncertainty that existing planning methods do not correlate with the actual dose.
• Significant Time Savings
  • Engineered for Y90 efficiency, demonstrating a 70% reduction in time compared to manual outlining of the liver.
• Post-Operative Dosimetry Calculation
  • Calculates dose using Y90-PET and Bremsstrahlung SPECT, including isodose curves/DVH on PET/SPECT using Local Disposition Method or MIRD Kernal.
• Flexible Workflows
  • Allows quick access and execution of pretreatment and posttreatment workflows from a sidebar menu.